InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Evolus, Inc.

EOLS Clue Score45
United States Fiscal year ends December CIK 0001570562 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

142
Insider
Date
Role
Action
Shares
Price
Amount
David Moatazedi
2 Sep 2026
See Remarks
Sell
105,108
$9.04
$950.02K
David Moatazedi
20 Mar 2026
See Remarks
Sold on a plan
13,669
$4.75
$64.93K
Rui Avelar
20 Mar 2026
See Remarks
Sell
3,119
$4.75
$14.82K
Rui Avelar
17 Mar 2026
See Remarks
Sold on a plan
29,996
$4.89
$146.63K
David Moatazedi
17 Mar 2026
See Remarks
Sold on a plan
116,720
$4.89
$570.56K
Rui Avelar
22 Dec 2025
See Remarks
Sold on a plan
2,261
$7.15
$16.17K
David Moatazedi
22 Dec 2025
See Remarks
Sold on a plan
10,539
$7.15
$75.36K
Tomoko Yamagishi-Dressler
22 Aug 2025
Chief Marketing Officer
Sold on a plan
5,722
$7.51
$42.97K
Brady Stewart
15 Aug 2025
Director
Buy
30,000
$6.82
$204.49K
David Moatazedi
16 Jun 2025
See Remarks
Sell
16,582
$9.89
$164.05K
David Moatazedi
13 Jun 2025
See Remarks
Sell
111,323
$10.05
$1.12M
Albert G White III
9 Jun 2025
Director
Buy
20,000
$9.45
$189.00K
Sandra Beaver
13 May 2025
Chief Financial Officer
Sold on a plan
6,494
$10.02
$65.07K
David Moatazedi
12 May 2025
See Remarks
Sold on a plan
15,787
$9.87
$155.76K
Rui Avelar
12 May 2025
See Remarks
Sold on a plan
3,385
$9.87
$33.40K
David Moatazedi
27 Mar 2025
See Remarks
Sold on a plan
6,251
$12.40
$77.51K
David Moatazedi
18 Mar 2025
See Remarks
Sold on a plan
103,376
$13.26
$1.37M
Tomoko Yamagishi-Dressler
18 Mar 2025
Chief Marketing Officer
Sold on a plan
4,536
$13.26
$60.12K
Sandra Beaver
18 Mar 2025
Chief Financial Officer
Sold on a plan
8,996
$13.26
$119.24K
Rui Avelar
18 Mar 2025
See Remarks
Sold on a plan
27,904
$13.26
$369.87K
Karah Herdman Parschauer
12 Mar 2025
Director
Sell
12,888
$12.99
$167.47K
David Moatazedi
23 Dec 2024
See Remarks
Sold on a plan
10,502
$10.85
$113.97K
Sandra Beaver
23 Dec 2024
Chief Financial Officer
Sold on a plan
1,586
$10.85
$17.21K
Rui Avelar
23 Dec 2024
See Remarks
Sold on a plan
2,252
$10.85
$24.44K
Sandra Beaver
6 Sep 2024
Chief Financial Officer
Sell
3,276
$14.98
$49.07K
Tomoko Yamagishi-Dressler
30 Aug 2024
Chief Marketing Officer
Sell
5,631
$15.85
$89.25K
David Moatazedi
6 Jun 2024
See Remarks
Sold after exercise
175,940
$12.59
$2.21M
David Moatazedi
5 Jun 2024
See Remarks
Sold after exercise
155,278
$12.92
$2.01M
David Moatazedi
4 Jun 2024
See Remarks
Sell
140,214
$12.73
$1.78M
Vikram Malik
3 Jun 2024
Director
Sell
7,500
$12.96
$97.20K
David N Gill
14 May 2024
Director
Sell
6,718
$12.60
$84.65K
Vikram Malik
13 May 2024
Director
Sell
28,000
$12.93
$362.01K
David N Gill
13 May 2024
Director
Sell
3,643
$12.72
$46.36K
Sandra Beaver
10 May 2024
Chief Financial Officer
Sell
2,423
$12.72
$30.81K
Rui Avelar
10 May 2024
See Remarks
Sell
3,441
$12.72
$43.76K
David Moatazedi
10 May 2024
See Remarks
Sell
16,051
$12.72
$204.13K
David Moatazedi
27 Mar 2024
See Remarks
Sell
6,236
$13.86
$86.43K
David Moatazedi
19 Mar 2024
See Remarks
Sell
96,566
$13.92
$1.34M
Sandra Beaver
19 Mar 2024
Chief Financial Officer
Sell
5,672
$13.92
$78.98K
Rui Avelar
19 Mar 2024
See Remarks
Sell
27,603
$13.92
$384.35K
Sandra Beaver
22 Feb 2024
Chief Financial Officer
Sold on a plan
1,821
$13.08
$23.82K
Rui Avelar
22 Feb 2024
See Remarks
Sold on a plan
1,821
$13.08
$23.82K
David Moatazedi
22 Feb 2024
See Remarks
Sold on a plan
7,706
$13.08
$100.80K
Karah Herdman Parschauer
30 Jan 2024
Director
Sold on a plan
11,931
$13.14
$156.73K
David Moatazedi
8 Dec 2023
See Remarks
Sell
31,300
$9.73
$304.51K
David Moatazedi
6 Dec 2023
See Remarks
Sell
51,348
$10.09
$517.89K
Medytox Inc.
16 Oct 2023
Former 10% Owner
Sell
1,690,663
$7.50
$12.68M
Sandra Beaver
6 Sep 2023
Chief Financial Officer
Sold on a plan
3,178
$9.70
$30.83K
David Moatazedi
16 Aug 2023
See Remarks
Sold on a plan
14,778
$10.27
$151.77K
Sandra Beaver
16 Aug 2023
Chief Financial Officer
Sold on a plan
2,211
$10.27
$22.71K
Rui Avelar
16 Aug 2023
See Remarks
Sold on a plan
2,211
$10.27
$22.71K
Vikram Malik
15 Aug 2023
Director
Buy
174,967
$7.41
$1.30M
David Moatazedi
27 Mar 2023
See Remarks
Sold on a plan
6,110
$8.47
$51.75K
Rui Avelar
14 Mar 2023
See Remarks
Sell
14,906
$8.47
$126.24K
David Moatazedi
14 Mar 2023
See Remarks
Sell
64,211
$8.47
$543.80K
Alphaeon 1 LLC
17 Feb 2023
10% owner
Sell
1,850,000
$8.40
$15.54M
Medytox Inc.
7 Feb 2023
10% owner
Sell
2,187,511
$8.50
$18.59M
Medytox Inc.
20 Jan 2023
10% owner
Sell indirect
37,043
$11.04
$408.95K
Medytox Inc.
6 Oct 2022
10% owner
Sell
38,304
$8.99
$344.42K
Medytox Inc.
5 Oct 2022
10% owner
Sell
6,848
$8.95
$61.29K
Medytox Inc.
15 Sep 2022
10% owner
Sell
24,000
$10.34
$248.10K
Medytox Inc.
14 Sep 2022
10% owner
Sell
73,000
$10.27
$749.67K
Robert Hayman
12 Sep 2022
Director
Buy indirect
1,091
$10.78
$11.76K
Medytox Inc.
9 Sep 2022
10% owner
Sell
20,700
$10.53
$217.91K
Robert Hayman
9 Sep 2022
Director
Buy indirect
8,909
$10.35
$92.18K
Medytox Inc.
8 Sep 2022
10% owner
Sell
15,300
$10.39
$158.98K
Robert Hayman
7 Sep 2022
Director
Buy
4,967
$10.05
$49.92K
Peter C Farrell
6 Sep 2022
Director
Buy indirect
10,000
$9.10
$91.05K
Simone Blank
6 Sep 2022
Director
Buy
20,000
$9.24
$184.84K
Medytox Inc.
1 Aug 2022
10% owner
Sell
26,000
$13.28
$345.36K
Lauren P Silvernail
18 May 2022
See Remarks
Sell
52,015
$12.42
$646.03K
Lauren P Silvernail
17 May 2022
See Remarks
Sell
16,189
$13.92
$225.35K
David N Gill
16 May 2022
Director
Sell
5,000
$13.62
$68.08K
David Moatazedi
16 May 2022
See Remarks
Sell
55,321
$13.64
$754.31K
David N Gill
13 May 2022
Director
Sell
5,313
$13.10
$69.58K
David Moatazedi
28 Mar 2022
See Remarks
Sell
6,104
$11.62
$70.93K
Lauren P Silvernail
8 Mar 2022
See Remarks
Sell
10,192
$9.73
$99.12K
Rui Avelar
8 Mar 2022
See Remarks
Sell
10,192
$9.73
$99.12K
David Moatazedi
8 Mar 2022
See Remarks
Sell
37,972
$9.73
$369.29K
Crystal Muilenburg
8 Mar 2022
Chief Marketing Officer
Sell
6,495
$9.73
$63.17K
Alphaeon 1 LLC
2 Sep 2021
10% owner
Sell
2,597,475
$9.50
$24.68M
Medytox Inc.
27 Aug 2021
10% owner
Buy
51,000
$10.93
$557.57K
Medytox Inc.
26 Aug 2021
10% owner
Buy
66,000
$11.02
$727.41K
Medytox Inc.
25 Aug 2021
10% owner
Buy
44,000
$11.12
$489.39K
Medytox Inc.
24 Aug 2021
10% owner
Buy
72,219
$11.17
$807.03K
Medytox Inc.
23 Aug 2021
10% owner
Buy
69,781
$11.03
$769.78K
Vikram Malik
23 Aug 2021
Director
Sell indirect
26,077
$11.00
$286.72K
Vikram Malik
20 Aug 2021
Director
Sell indirect
49,878
$10.61
$529.32K
Medytox Inc.
20 Aug 2021
10% owner
Buy
48,000
$10.56
$506.70K
Vikram Malik
19 Aug 2021
Director
Sell indirect
11,962
$10.50
$125.56K
Medytox Inc.
19 Aug 2021
10% owner
Buy
55,000
$10.51
$578.11K
Medytox Inc.
18 Aug 2021
10% owner
Buy
45,000
$10.54
$474.08K
Vikram Malik
18 Aug 2021
Director
Sell indirect
25,000
$10.44
$261.01K
Medytox Inc.
17 Aug 2021
10% owner
Buy
70,000
$10.69
$748.06K
Vikram Malik
17 Aug 2021
Director
Sell indirect
42,083
$10.06
$423.55K
Medytox Inc.
16 Aug 2021
10% owner
Buy
65,000
$11.34
$737.04K
David Moatazedi
16 Aug 2021
See Remarks
Sell
47,737
$11.35
$541.74K
Medytox Inc.
13 Aug 2021
10% owner
Buy
49,714
$10.98
$545.72K
David Moatazedi
13 Aug 2021
See Remarks
Sell
22,708
$10.66
$242.07K
Medytox Inc.
13 Aug 2021
10% owner
Buy indirect
14,043
$11.11
$156.06K
Medytox Inc.
12 Aug 2021
10% owner
Buy
39,126
$10.93
$427.71K
Medytox Inc.
12 Aug 2021
10% owner
Buy indirect
23,000
$10.99
$252.77K
Medytox Inc.
11 Aug 2021
10% owner
Buy
26,160
$10.77
$281.74K
David Moatazedi
10 Aug 2021
See Remarks
Sell
41,763
$11.18
$466.84K
Crystal Muilenburg
10 Aug 2021
Chief Marketing Officer
Sell
5,362
$11.18
$59.94K
Rui Avelar
10 Aug 2021
See Remarks
Sell
14,293
$11.18
$159.79K
Lauren P Silvernail
10 Aug 2021
See Remarks
Sell
14,293
$11.18
$159.77K
David Moatazedi
25 Jan 2021
See Remarks
Sell
8,310
$7.46
$61.99K
Rui Avelar
25 Jan 2021
See Remarks
Sell
2,699
$7.46
$20.13K
Michael M. Jafar
25 Jan 2021
See Remarks
Sell
2,699
$7.46
$20.13K
Lauren P Silvernail
25 Jan 2021
See Remarks
Sell
2,699
$7.46
$20.13K
Rui Avelar
7 Jan 2020
See Remarks
Sell
39,442
$10.71
$422.28K
Rui Avelar
10 Dec 2019
See Remarks
Exercised, kept
10,020
$9.98
$100.00K
David N Gill
13 Jun 2019
Director
Buy
2,000
$13.65
$27.30K
AEON Biopharma, Inc.
3 Jun 2019
10% owner
Sell
1,298,701
$19.25
$25.00M
Vikram Malik
3 Jun 2019
Director
Buy indirect
1,298,701
$19.25
$25.00M
Lauren P Silvernail
31 May 2019
See Remarks
Sell
2,612
$13.53
$35.35K
Kristine Romine
29 May 2019
Director
Buy indirect
2,090
$14.77
$30.86K
AEON Biopharma, Inc.
22 May 2019
10% owner
Sell
290,518
$19.25
$5.59M
AEON Biopharma, Inc.
20 May 2019
10% owner
Sell
1,017,422
$19.25
$19.59M
AEON Biopharma, Inc.
20 May 2019
10% owner
Sell
4,000,000
$19.25
$77.00M
Simone Blank
20 May 2019
Director
Buy indirect
628,536
$19.25
$12.10M
Kristine Romine
20 May 2019
Director
Buy
40,562
$19.25
$780.82K
Vikram Malik
17 Dec 2018
Director
Buy
7,800
$13.04
$101.69K
Kristine Romine
17 Dec 2018
Director
Buy
5,000
$12.75
$63.75K
David N Gill
14 Dec 2018
Director
Buy
3,000
$12.77
$38.30K
Kristine Romine
14 Dec 2018
Director
Buy
11,000
$12.50
$137.45K
AEON Biopharma, Inc.
29 Nov 2018
10% owner
Sell
573,888
$14.00
$8.03M
Kristine Romine
29 Nov 2018
Director
Buy
6,347
$14.00
$88.86K
Simone Blank
29 Nov 2018
Director
Buy indirect
295,024
$14.00
$4.13M
Michael M. Jafar
14 Sep 2018
Chief Marketing Officer
Buy
12,800
$20.83
$266.59K
AEON Biopharma, Inc.
11 Sep 2018
10% owner
Sell
1,750,000
$21.04
$36.82M
Kristine Romine
22 Aug 2018
Director
Buy
10,000
$19.83
$198.27K
AEON Biopharma, Inc.
23 Jul 2018
10% owner
Sell
1,000,000
$18.80
$18.80M
Vikram Malik
14 Jun 2018
Director
Buy
8,600
$28.88
$248.35K
Kristine Romine
8 Jun 2018
Director
Buy
2,000
$28.05
$56.10K
Kristine Romine
7 Jun 2018
Director
Buy indirect
200
$33.40
$6.68K
Bosun Hau
6 Jun 2018
Director
Buy
2,898
$34.94
$101.26K
Bosun Hau
4 Jun 2018
Director
Buy
7,142
$29.19
$208.47K
Kristine Romine
1 Jun 2018
Director
Buy
4,000
$25.74
$102.95K
Kristine Romine
31 May 2018
Director
Buy indirect
1,000
$24.40
$24.40K
Kristine Romine
31 May 2018
Director
Buy
2,000
$24.40
$48.80K

What was left out

Form 4 filings counted 224
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 26
Sales straight out of an exercise 2
Sales at will 69
Transactions with no price 0
Shares from compensation/vesting 15,064,534
Sales filed before the plan box existed 47
History held since 13 Feb 2018